NURIX THERAPEUTICS INC shareholders Q3 2023

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 129 filers reported holding NURIX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.

NURIX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MANUFACTURERS LIFE INSURANCE COMPANY, THE 19,244$151,2580.00%
LAZARD ASSET MANAGEMENT LLC 5,674$440.00%
Legal & General Group Plc 31,979$251,3560.00%
Mirae Asset Global Investments Co., Ltd. 27,375$215,1680.00%
BALYASNY ASSET MANAGEMENT L.P. 26,275$206,5220.00%
D. E. Shaw & Co., Inc. 25,358$199,3140.00%
TWO SIGMA ADVISERS, LP 19,200$150,9120.00%
JANUS HENDERSON GROUP PLC 12,933$101,7170.00%
NATIXIS 5,760$45,2740.00%
WELLS FARGO & COMPANY/MN 34,046$267,6010.00%
Daiwa Securities Group Inc. 152$10.00%
External links

This page lists NURIX THERAPEUTICS INC's shareholders in Q3 2023. To view NURIX THERAPEUTICS INC's shareholder history, click here.